ActivePhase 4ACTRN12606000004561
International, multicentre: Perhexiline in Aortic Stenosis study.
Effects of perhexiline on the symptomatic status in elderly patients with severe aortic stenosis.
Sponsor
The Queen Elizabeth Hospital,Cardiology Department
Enrollment
65 participants
Start Date
Jun 1, 1999
Study Type
Interventional
Conditions
Summary
Too see if perhexilin can decrease the symptoms of chest pain and breathlessness in people who have severe aortic stenosis.
Eligibility
Sex: Both males and females
Inclusion Criteria1
- AVA of < 0.1cm sq. Symptoms of angina and/or exertional shortness of breath.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Perhexiline 100mgs BD for 8 weeks.
Perhexiline 100mgs BD for 8 weeks.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12606000004561